Pyruvate dehydrogenase kinase 4 (PDK4), which phosphorylates and inhibits pyruvate dehydrogenase (PDH), is downregulated in HCC and associated with increased lipid biosynthesis and poor prognosis [58]. Here, PDK4 is linked to hepatocellular carcinoma.